Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Recalled by Qualigen Inc Due to Qualigen initiated this recall because the FastPack kit...

Date: November 8, 2013
Company: Qualigen Inc
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Qualigen Inc directly.

Affected Products

FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA. FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer. The FastPack Total PSA Immunoassay is designed for use with the FastPack System.

Quantity: 182

Why Was This Recalled?

Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.

Where Was This Sold?

This product was distributed to 16 states: AL, CA, IN, KS, KY, MA, NV, NY, NC, OK, SC, TN, TX, UT, VA, WA

Affected (16 states)Not affected

About Qualigen Inc

Qualigen Inc has 8 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report